How to Choose a T7 RNA Polymerase: Standard vs Low dsRNA vs Thermostable
Share this post:
Source: Hzymes Market Center
Date: 2026-10-26
Views: 6

T7 RNA polymerase is the core enzyme of mRNA in vitro transcription (IVT). It recognizes the T7 promoter and builds RNA in the 5′ to 3′ direction from a linear DNA template. Because every other step in the workflow depends on the RNA it produces, the polymerase you pick affects yield, RNA integrity, dsRNA content and even how you run the reaction.


Three types are in common use: a high-activity standard enzyme, a low dsRNA enzyme, and a thermostable enzyme. They overlap in what they can do, so the choice is less about which is "best" and more about which problem you most need to solve. This guide compares them side by side and finishes with a quick decision guide and a plan for testing them on your own template.


Key takeaways

•     Standard (high-activity) T7: choose it for yield, scale and difficult or long templates, including saRNA.

•     Low dsRNA T7: choose it when innate immune activation is the main concern. It lowers dsRNA at the source under normal 37 °C conditions, with no change to your IVT process.

•     Thermostable T7: choose it for templates with strong secondary structure or high GC content, for circRNA precursors, or when you want to develop a high-temperature IVT process.

•     The polymerase is only one lever on dsRNA. Modified nucleotides, reaction temperature and purification all matter too.

•     The most reliable way to decide is a side-by-side test on your own template.



Why the polymerase choice matters


Four questions usually decide which T7 polymerase fits a project:


•     Yield and activity: how much mRNA do you need per reaction, and how much does enzyme cost matter at your scale?

•     dsRNA and immunogenicity: will the mRNA go into primary cells or animals, where dsRNA byproducts can trigger innate immune sensors such as RIG-I, MDA5 and PKR?

•     Template complexity: is your template long, GC-rich, or prone to strong secondary structure?

•     Process requirements: do you need to keep an existing 37 °C process unchanged, or are you free to develop a new one? Do you need GMP-compliant, animal-origin-free materials?



The three HZYMES T7 RNA polymerases at a glance


 

Standard (high activity)

Low dsRNA

Thermostable

Cat. No.

HBP000330

HBP000340

HBP000350

What it is

Engineered M6 variant with activity-enhancing substitutions

Engineered variant that generates fewer dsRNA byproducts than wild-type

Directed-evolution mutant with improved thermostability and catalytic activity

Headline data (vs wild-type)

About 3.8-fold higher specific activity (U/mg). Over 10-fold higher solution activity (U/mL) from improved oxidative stability

dsRNA typically reduced by more than 10-fold at standard 37 °C conditions

270-fold longer half-life and 58-fold higher activity at 52 °C. Fully active at 37 °C

dsRNA

Lower than wild-type

Lowest of the three; also lowered IFN-α and IL-6 in transfected RAW cells in HZYMES testing

High-temperature IVT can help reduce dsRNA byproducts and immunogenicity

Template strengths

Varied lengths (tested from 500 to 4000 nt), challenging sequences, saRNA and other long RNAs

Broad template compatibility with consistent yield and integrity

Stable secondary structures and GC-rich regions

Special uses

Large-scale production

Personalized cancer vaccines, gene editing, protein replacement therapy

circRNA precursors, high-temperature IVT process development

 

All three are supplied at 50 U/µL. They are produced and quality-controlled under GMP-compliant procedures with traceability of the production process and all raw and auxiliary materials. Production is animal-origin free and uses no ampicillin or other β-lactam antibiotics, and residual endonuclease, exonuclease, nickase, RNase and endotoxin are controlled. Transport below 0 °C and store at −25 to −15 °C.



Standard (high-activity) T7: for yield and scale


The standard enzyme is not a plain wild-type T7. It is an engineered M6 variant, so it delivers more transcription per unit of protein. Its improved oxidative stability prevents enzyme aggregation even without reducing agents, which is why its activity per milliliter of enzyme solution is over 10-fold higher than that of the wild-type enzyme.


Choose it when:


•     You want maximum mRNA output per reaction and lower manufacturing cost at scale.

•     Your templates vary in length or include sequences that normally give low yield or poor integrity.

•     You are making saRNA or other long RNA templates.


It also produces transcripts with lower dsRNA content than wild-type. If dsRNA is your top priority, however, the low dsRNA enzyme is built specifically for that.



Low dsRNA T7: when immunogenicity is the concern


T7 polymerase can generate dsRNA byproducts during IVT, for instance through 3′ extension of transcripts or antisense RNA. These byproducts are recognized by innate immune sensors, which can lower expression and cause unwanted inflammation. Removing them afterwards adds purification burden, so reducing them at the source is attractive.


The HZYMES low dsRNA enzyme works under conventional 37 °C conditions, so existing IVT parameters do not need to change. dsRNA levels are typically reduced by more than 10-fold across a broad range of templates, while yield and RNA integrity are maintained. In HZYMES testing, mRNA made with it and transfected into RAW cells produced lower levels of IFN-α and IL-6.


Choose it when:


•     The mRNA will be used in vivo, in primary cells, or in other settings where innate immune activation matters.

•     You are developing personalized cancer vaccines, gene editing mRNA or protein replacement therapies that need low immunogenicity and high transcript quality.

•     You want lower dsRNA without changing your current process or temperature.



Thermostable T7: for structured templates and new processes


The thermostable enzyme was developed through multiple rounds of directed iterative evolution. At 52 °C its half-life is 270-fold longer and its activity 58-fold higher than wild-type. It also keeps its activity at 37 °C, so it can replace wild-type T7 without redesigning a standard process.


Running IVT at higher temperatures reduces the impact of RNA secondary structure, which helps with GC-rich or highly structured templates. Higher temperatures may also reduce dsRNA byproduct formation and the immunogenicity of the product, and can lower the downstream purification burden.


Choose it when:


•     Your template contains stable secondary structures or GC-rich regions that are hard to transcribe.

•     You are producing precursor RNA for circRNA, where it supports high-quality transcripts and can improve self-circularization efficiency.

•     You want to develop a high-temperature IVT workflow for process optimization.


It is compatible with modified substrates, so it can also make biotin-, dye- or radiolabeled RNA, and capped RNA using cap structures or cap analogs.



A quick decision guide


If your priority is…

Start with

Highest yield, scale-up, or long templates such as saRNA

Standard (HBP000330)

Lowest dsRNA with no change to your 37 °C process

Low dsRNA (HBP000340)

mRNA for primary cells, in vivo studies or other immune-sensitive uses

Low dsRNA (HBP000340), together with modified nucleotides and suitable purification

GC-rich or strongly structured templates

Thermostable (HBP000350)

circRNA precursor production

Thermostable (HBP000350)

Developing a high-temperature IVT process

Thermostable (HBP000350)

Replacing wild-type T7 with minimal process change

Low dsRNA or Thermostable, both of which work at 37 °C

 

If you need both low dsRNA and high-temperature performance, test the options side by side on your own template, and talk to the HZYMES technical team about the best combination for your process.



Beyond the polymerase: other ways to control dsRNA


•     Modified nucleotides: replacing UTP with pseudo-UTP or N1-methylpseudo-UTP reduces recognition by innate immune sensors and can improve translation.

•     Reaction temperature: higher temperatures, enabled by a thermostable enzyme, may reduce dsRNA formation.

•     Template design: a cleanly linearized template with a defined end reduces run-on products.

•     Purification: cleanup steps can remove residual dsRNA, and the amount to remove is smaller when less is produced.

•     Measurement: check dsRNA content with an antibody-based dot blot or ELISA rather than assuming.



Ready-to-use options built around each polymerase


If you prefer a complete system to formulating the reaction yourself, each polymerase has matching reagents:


Polymerase

Hi-yield IVT reagent and co-capping options

Enzyme mix

Standard (HBP000330)

Hi-yield T7 IVT reagent (N1-Me-pUTP) HBP001505; (pUTP) HBP001506; co-capping reagents HBP001507 to HBP001510

Enzyme Mix HBP000331; 

Enzyme Mix 2.0 HBP000332

Low dsRNA (HBP000340)

Hi-yield T7 IVT reagent (Low dsRNA) HBP001511

Enzyme Mix (low dsRNA) HBP000341

Thermostable (HBP000350)

Hi-yield T7 IVT reagent (Thermostable) HBP001512

Enzyme Mix (thermostable) HBP000351



How to test the three on your own template


Product data show how each enzyme performs in general. Your template and process are specific, so a short comparison is worth the time:


1.      Use the same template, the same NTPs and the same buffer and cleanup for all enzymes.

2.      Run each enzyme at the temperature you plan to use in production. Include 37 °C for all, and an elevated temperature for the thermostable enzyme.

3.      Measure yield and RNA integrity, for example by capillary electrophoresis.

4.      Measure dsRNA content with an antibody-based method.

5.      If the mRNA is for cells or animals, add a functional readout such as expression, and an immune marker if relevant.

6.      Pick the enzyme that meets your most important requirement, then confirm it at the scale you plan to use.



Frequently asked questions


What is the difference between low dsRNA and thermostable T7 RNA polymerase?

The low dsRNA enzyme reduces dsRNA byproducts at the usual 37 °C, with no process change. The thermostable enzyme is built for high-temperature IVT, which helps with structured templates and may also reduce dsRNA. Low dsRNA is the more direct choice when dsRNA is the main concern; thermostable is the more direct choice for difficult templates and high-temperature process development.


Can I replace wild-type T7 RNA polymerase without redesigning my process?

The low dsRNA enzyme requires no change to existing IVT parameters at 37 °C, and the thermostable enzyme stays active under conventional 37 °C conditions, so it can serve as a direct replacement. As with any enzyme change, confirm performance on your own template.


Can these enzymes make modified, labeled or capped RNA?

The thermostable enzyme is compatible with modified substrates and can make biotin-, dye- or radiolabeled RNA, as well as capped RNA using cap structures or cap analogs.


Which template do these enzymes use?

A linear double-stranded DNA template containing a T7 promoter. The enzyme transcribes the sequence downstream of the promoter.


Are these enzymes suitable for GMP manufacturing?

They are suitable for both GMP-scale manufacturing and preclinical development of mRNA vaccines, gene therapies and other RNA-based therapeutics. They are produced and quality-controlled under GMP-compliant procedures, in an animal-origin-free process that uses no ampicillin or other β-lactam antibiotics.


How should I store and transport them?

Transport below 0 °C and store at −25 to −15 °C.


Talk to the HZYMES team

Not sure which T7 RNA polymerase fits your template? Request a quote or sample, or ask our technical team to help you design a side-by-side test.

[Insert links: Request Quote | Request Sample | Technical Support]



Related reading (to be linked as published)


•     mRNA In Vitro Transcription (IVT): A Complete Workflow Guide, from DNA Template to LNP Delivery

•     dsRNA Byproducts in IVT: Causes, Impact on Immunogenicity, and How to Reduce Them

•     Thermostable T7 RNA Polymerase: When High-Temperature IVT Makes Sense

•     Troubleshooting IVT: Low Yield, Truncated Transcripts, and Inconsistent Batches

•     Modified Nucleotides in mRNA: Pseudo-UTP vs N1-Me-Pseudo-UTP


Product specifications and availability are listed on each product page.

Message
Leave Your Message
Name *
Company *
Tel/WhatsApp *
Mail *
Nation *
Descriptions

Please contact on WhatsApp

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

  • iso_copy_copy
  • iso_copy
  • iso
  • iso_copy_copy
  • iso_copy
  • iso
Contact Us

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China.

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

Copyright © Hzymes Biotechnology Co., Ltd. All Rights Reserved Web design

Site Map | Legal Notice | Privacy Policy |

Contact Us